Clinical Evaluation of a Hyperbolic Paraboloid Triple-Abutment on Morse Taper Dental Implants
Biomechanical and Clinical Effects of a Hyperbolic Paraboloid Triple-Abutment System on Morse Taper Dental Implants: Prospective Clinical Study With Finite Element Corroboration
1 other identifier
observational
30
1 country
1
Brief Summary
This prospective clinical study aims to evaluate the clinical and radiographic outcomes of a novel triple-abutment system with hyperbolic paraboloid geometry installed on Morse taper dental implants. The system is designed to support three adjacent crowns on a single implant, aiming to optimize load distribution and preserve peri-implant tissue stability. Thirty systemically healthy adults missing three adjacent teeth will undergo implant placement, followed by a healing period of approximately three months for osseointegration prior to prosthetic loading. Metal-ceramic restorations will then be cemented over triple abutments. Clinical and radiographic evaluations will be performed at T1 (3-4 months after prosthetic loading) and T2 (12-18 months after prosthetic loading). The primary outcome will be marginal bone level change assessed by standardized periapical radiographs. Secondary outcomes include probing depth, bleeding on probing, plaque index, keratinized mucosa height, and patient-reported satisfaction. The study aims to investigate whether this innovative abutment design provides stable peri-implant conditions and favorable clinical performance when applied to Morse taper implants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2025
CompletedStudy Start
First participant enrolled
December 29, 2025
CompletedFirst Posted
Study publicly available on registry
December 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 29, 2028
January 2, 2026
December 1, 2025
6 months
December 16, 2025
December 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Marginal Bone Level (mm)
Marginal bone level measured in millimeters at the mesial and distal aspects of each implant using standardized periapical radiographs with the parallel technique and calibrated measurements, assessed at T1 (3-4 months)
baseline vs. 3 months
Secondary Outcomes (11)
Changes in Marginal Bone Level (mm)
baseline vs. 12-18 months after prosthetic loading
Changes in Peri-Implant Probing Depth
baseline versus 3-4 months (T2) after prosthetic loading
Changes in Peri-Implant Probing Depth
baseline versus 12-18 months (T2) after prosthetic loading
Presence of Bleeding on Probing
baseline versus 3-4 months (T2) after prosthetic loading
Presence of Bleeding on Probing
baseline versus 12-18 months (T2) after prosthetic loading
- +6 more secondary outcomes
Interventions
Prosthetic loading will be performed on osseointegrated morse taper dental implants using a fixed implant-supported rehabilitation with a triple-abutment system featuring hyperbolic paraboloid geometry. Metal-ceramic prostheses will be cemented over the abutment components. All procedures will be performed by a single operator.
Eligibility Criteria
A convenience sample will be composed of adult patients with three adjacent missing teeth who underwent placement of a Morse taper dental implant, followed by a healing period of approximately three months for osseointegration. After confirmation of osseointegration, participants will be eligible for fixed implant-supported rehabilitation using a triple-abutment system designed to support a three-unit prosthesis on a single implant, according to clinical planning.
You may qualify if:
- Adults aged ≥ 18 years.
- Systemically healthy as determined by medical history and clinical assessment.
- Non-smokers (no tobacco use).
- Able and willing to comply with study visits and maintenance program, and provide written informed consent.
You may not qualify if:
- diabetes mellitus (any type) or uncontrolled systemic disease.
- current or recent tobacco/nicotine use
- bisphosphonates or other antiresorptives,
- immunosuppressive therapy,
- osteoporosis
- pregnancy or lactation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Federal University of Minas Gerais, Dental School
Belo Horizonte, Minas Gerais, 31270-901, Brazil
Study Officials
- PRINCIPAL INVESTIGATOR
Fernando O Costa, PhD
Federal University of Minas Gerais
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Titular professor
Study Record Dates
First Submitted
December 16, 2025
First Posted
December 30, 2025
Study Start
December 29, 2025
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
December 29, 2028
Last Updated
January 2, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make individual participant data available to other researchers.